GILEAD SCIENCES INC 4
4 · GILEAD SCIENCES INC · Filed Feb 7, 2007
Insider Transaction Report
Form 4
Yang Taiyin
SVP, Pharm Dev & Mfg
Transactions
- Sale
Common Stock
2007-02-06$70.22/sh−15,900$1,116,498→ 186,381 total - Sale
Common Stock
2007-02-06$70.24/sh−4,100$287,984→ 202,281 total
Holdings
- 3,992(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Amount of Securities Beneficially Owned Following Reported Transaction (s) (Table 1, Col. 5) includes 720 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2006.